Today's Date
Omalizumab (Xolair) and Allergy Shots For the Treatment of Seasonal Allergies
(
)
ITN Protocol #:
ITN019AD
Branded Name:
ClinicalTrials.Gov ID:
NCT00078195Treatment Protocol #:
Therapeutic Area:
Allergy & Asthma
Current Status:
Complete
Summary:
Allergen immunotherapy Co-administered with Omalizumab
